• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

GLP-1

Physicians Reveals GLP-1s for Weight Loss are Overprescribed and Unsustainable

by Jasmine Pennic 08/06/2024 Leave a Comment

Physicians Reveals GLP-1s for Weight Loss are Overprescribed and Unsustainable,

What You Should Know:  - A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal.  - The Virta Health survey was conducted in partnership with Beresford Research and included 300 primary care providers, endocrinologists, and obesity specialists across the United States sheds light on the medical community's views on the rapidly growing class of GLP-1 medications, often hailed as
Read More

Nestlé Health Science Launches Innovative GLP-1 Nutrition Platform

by Jasmine Pennic 06/25/2024 Leave a Comment

Nestlé Health Science Launches Innovative GLP-1 Nutrition Platform

What You Should Know:  - Nestlé Health Science, a global leader in nutritional science, today announced the launch of glp-1nutrition.com, a web platform designed to support individuals on their weight management journey, particularly those using GLP-1 medications. - The launch of glp-1nutrition.com reflects their ongoing commitment to empowering healthier lives through targeted nutritional guidance. GLP-1nutrition.com: Your One-Stop Shop for GLP-1 Weight Management Support The
Read More

Aranscia and SignatureRX Partner to Optimize GLP-1 Medication Use

by Jasmine Pennic 06/21/2024 Leave a Comment

Aranscia and SignatureRX Partner to Optimize GLP-1 Medication Use

What You Should Know:  - Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.  - The multi-phase partnership focuses on developing personalized treatment plans and ensuring consistent access to these crucial medications. GLP-1s: Beyond Type 2 Diabetes Glucagon-like peptide-1 receptor agonists (GLP-1s) were initially developed for type 2 diabetes
Read More

Weekly Ozempic/Wegovy Injections May Lower Kidney Failure Risk, Study Finds

by Jasmine Pennic 05/28/2024 Leave a Comment

What You Should Know:  - A new study suggests that a weekly treatment with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly reduce the risk of kidney failure and other complications in patients with type 2 diabetes and chronic kidney disease (CKD).Find semaglutide online today. - Funded by Novo Nordisk creators of Ozempic and Wegovy semaglutide injections for diabetes management, the study published in The New England Journal of Medicine investigated
Read More

Dandelion Health Launches First Multimodal GLP-1 Data Library for Precision Medicine

by Jasmine Pennic 05/14/2024 Leave a Comment

Dandelion Health Launches First Multimodal GLP-1 Data Library for Precision Medicine

What You Should Know:  - Dandelion Health, a leader in real-world data (RWD) and clinical AI, has unveiled the industry's first-ever multimodal GLP-1 data library.  - The multimodal GLP-1 data library empowers researchers and life sciences companies to unlock deeper insights into the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs for precision medicine. Unprecedented Depth of Real-World Data Gathered from Dandelion's network of collaborating medical centers,
Read More

LifeMD Integrates with Withings: GLP-1 Weight Loss with In-Home Monitoring

by Syed Hamza Sohail 05/02/2024 Leave a Comment

LifeMD Integrats with Withings: GLP-1 Weight Loss with In-Home Monitoring

 What You Should Know: -              LifeMD, Inc.® (Nasdaq: LFMD), a leading provider of virtual primary care services, and Withings Health Solutions, a leader in digital health technology, announce a new strategic partnership designed to revolutionize weight management patient care by providing LifeMD's GLP-1 weight-loss patients with Withings advanced in-home health monitoring devices, including the Body Pro 2 scale and
Read More

Lexaria Conducts Second Human Trial for Improved Oral GLP-1 Delivery

by Fred Pennic 03/10/2024 Leave a Comment

Lexaria Conducts Second Human Trial for Improved Oral GLP-1 Delivery

What You Should Know: - Lexaria Bioscience Corp. is pushing the boundaries of oral drug delivery with their latest clinical trial. - The company announced they have contracted a research organization (CRO) to conduct a second human pilot study on their DehydraTECH-powered glucagon-like peptide-1 (GLP-1) treatment. GLP-1 Challenges and Lexaria's Solution GLP-1 drugs, like semaglutide, are currently delivered through injections or tablets. However, these methods have limitations.
Read More

Teladoc Health Expands Obesity & Weight Management Capabilities with GLP-1 Support

by Syed Hamza Sohail 03/07/2024 Leave a Comment

Teladoc Health Expands Obesity & Weight Management Capabilities with GLP-1 Support

What You Should Know: Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as glucagon-like peptide 1 (GLP-1) agonists and support safe, sustainable weight loss and cardiometabolic health improvement for members.New features include helping plan sponsors and pharmacy benefit managers manage and optimize the growing complexity and
Read More

WeightWatchers Launches First-Of-Its-Kind GLP-1 Program + WeightWatchers Clinic

by Jasmine Pennic 12/14/2023 Leave a Comment

WeightWatchers Launches First-Of-Its-Kind GLP-1 Program + WeightWatchers Clinic

What You Should Know: - WeightWatchers launches two new offerings to further support individuals on their journeys to better health: the WeightWatchers GLP-1 Program and WeightWatchers Clinic integration within the WeightWatchers App. - By focusing on personalization, scientific evidence, and comprehensive support, WW empowers individuals to take control of their weight health and achieve lasting results. WeightWatchers GLP-1 Program This program addresses the unique needs of
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |